Quantitative Flow Ratio to Predict Non-Target-Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.

"Disclosures Dr Bär reports research grants to the institution from Medis Medical Imaging Systems, Abbott, and Bangerter‐Rhyner Stiftung, and a personal research grant from the Swiss National Science Foundation, outside the submitted work. Dr Ueki reports personal fees from Infraredex, outside the submitted work. Dr Losdat is employed by CTU Bern, University of Bern, which has a staff policy of not accepting honoraria or consultancy fees. However, CTU Bern is involved in design, conduct, or analysis of clinical studies funded by not‐for‐profit and for‐profit organizations. In particular, pharmaceutical and medical device companies provide direct funding to some of these studies. An up‐to‐date list of CTU Bern's conflicts of interest can be found at http://www.ctu.unibe.ch/research/declaration_of_interest/index_eng.html. Dr Praz has received travel expenses from Abbott Vascular, Edwards Lifesciences, and Polares Medical. Dr Häner has received a travel grant from Bayer. Dr Stortecky reports research grants to the institution from Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific; speaker fees from Boston Scientific; and consulting fees from BTG and Teleflex, outside the submitted work. Dr Pilgrim reports research grants to the institution from Boston Scientific, Biotronik, and Edwards Lifesciences; speaker fees from Boston Scientific and Biotronik; consultancy for HighLife SAS; and proctoring for Boston Scientific and Medtronic. Dr Windecker reports research, travel, or educational grants to the institution without personal remuneration from Abbott, Abiomed, Amgen, AstraZeneca, Bayer, Braun, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardinal Health, CardioValve, Cordis Medical, Corflow Therapeutics, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Farapulse Inc., Fumedica, Guerbet, Idorsia, Inari Medical, InfraRedx, Janssen‐Cilag, Johnson & Johnson, Medalliance, Medicure, Medtronic, Merck Sharp & Dohm, Miracor Medical, Novartis, Novo Nordisk, Organon, OrPha Suisse, Pharming Tech. Pfizer, Polares, Regeneron, Sanofi‐Aventis, Servier, Sinomed, Terumo, Vifor, and V‐Wave. Dr Windecker served as advisory board member or member of the steering/executive group of trials funded by Abbott, Abiomed, Amgen, AstraZeneca, Bayer, Boston Scientific, Biotronik, Bristol Myers Squibb, Edwards Lifesciences, MedAlliance, Medtronic, Novartis, Polares, Recardio, Sinomed, Terumo, and V‐Wave with payments to the institution but no personal payments. He is also member of the steering/executive committee group of several investigator‐initiated trials that receive funding by industry without impact on his personal remuneration. Dr Räber reports research grants to the institution from Abbott Vascular, Biotronik, Boston Scientific, Heartflow, Sanofi, Regeneron, Medis Medical Imaging Systems, and Bangerter‐Rhyner Stiftung; speaker or consultation fees by Abbott Vascular, Amgen, AstraZeneca, Canon, Novo Nordisk, Medtronic, Occlutech, and Sanofi, outside the submitted work. The remaining authors have no disclosures to report."

"Sources of Funding None."

"Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02241291."